"There is no Cure for Muscular Skeletal Injuries,
                         Only BODY Maintenance"
                                                     Kate Montgomery

More then 16 million people in the U.S. (and 250 million worldwide) suffer from type II diabetes.  The prevalence is increasing by approximately 5 percent each year, with an estimated 40-45 percent of people over 65 years old at risk.

After several years of extensive studies, Maitake Products (in conjunction with Harry G. Preuss, M.D. of Georgetown University) has developed Grifron® SX-fraction™.  

Studies at Georgetown University (started in 1997) and NY Medical College show that SX-Fraction "does indeed possess the ability to enhance insulin sensitivity for controlling blood sugar levels and lower high blood pressure.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.